224 related articles for article (PubMed ID: 30894518)
1. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress.
Liang L; Li L; Tian J; Lee SO; Dang Q; Huang CK; Yeh S; Erturk E; Bushinsky D; Chang LS; He D; Chang C
Mol Endocrinol; 2014 Aug; 28(8):1291-303. PubMed ID: 24956378
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.
Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H
Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994
[TBL] [Abstract][Full Text] [Related]
4. AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.
Yang X; Liu H; Ye T; Duan C; Lv P; Wu X; Liu J; Jiang K; Lu H; Yang H; Xia D; Peng E; Chen Z; Tang K; Ye Z
Theranostics; 2020; 10(26):12011-12025. PubMed ID: 33204326
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
Front Immunol; 2021; 12():673690. PubMed ID: 34108970
[TBL] [Abstract][Full Text] [Related]
6. The Protective Roles of Estrogen Receptor
Zhu W; Zhao Z; Chou FJ; Zuo L; Liu T; Bushinsky D; Chang C; Zeng G; Yeh S
Oxid Med Cell Longev; 2019; 2019():5305014. PubMed ID: 31178964
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 3 suppresses the formation of renal calcium oxalate crystals through promoting M2 polarization of macrophages.
Xi J; Chen Y; Jing J; Zhang Y; Liang C; Hao Z; Zhang L
J Cell Physiol; 2019 Jul; 234(7):11463-11473. PubMed ID: 30588609
[TBL] [Abstract][Full Text] [Related]
8. Colony-stimulating factor-1 signaling suppresses renal crystal formation.
Taguchi K; Okada A; Kitamura H; Yasui T; Naiki T; Hamamoto S; Ando R; Mizuno K; Kawai N; Tozawa K; Asano K; Tanaka M; Miyoshi I; Kohri K
J Am Soc Nephrol; 2014 Aug; 25(8):1680-97. PubMed ID: 24578130
[TBL] [Abstract][Full Text] [Related]
9. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation.
Wang X; Xie L; Liu C
Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255
[TBL] [Abstract][Full Text] [Related]
10. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
11. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.
Dominguez-Gutierrez PR; Kusmartsev S; Canales BK; Khan SR
Front Immunol; 2018; 9():1863. PubMed ID: 30186283
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization.
Song BF; Li BJ; Ning JZ; Xia YQ; Ye ZH; Yuan TH; Yan XZ; Li L; Zhou XJ; Rao T; Li W; Cheng F
Int Immunopharmacol; 2023 Aug; 121():110398. PubMed ID: 37301123
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for stone disease.
Dominguez-Gutierrez PR; Kwenda EP; Khan SR; Canales BK
Curr Opin Urol; 2020 Mar; 30(2):183-189. PubMed ID: 31913203
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin1 inhibits calcium oxalate crystal-induced kidney injury by regulating TLR4 signaling and macrophage-mediated inflammatory activation.
Duan C; Liu H; Yang X; Liu J; Deng Y; Wang T; Xing J; Hu Z; Xu H
Cell Signal; 2023 Dec; 112():110887. PubMed ID: 37717713
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
16. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.
Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H
Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472
[TBL] [Abstract][Full Text] [Related]
17. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.
Mulay SR; Kulkarni OP; Rupanagudi KV; Migliorini A; Darisipudi MN; Vilaysane A; Muruve D; Shi Y; Munro F; Liapis H; Anders HJ
J Clin Invest; 2013 Jan; 123(1):236-46. PubMed ID: 23221343
[TBL] [Abstract][Full Text] [Related]
18. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.
Khan SR; Glenton PA
J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545
[TBL] [Abstract][Full Text] [Related]
19. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Chen Z; Yuan P; Sun X; Tang K; Liu H; Han S; Ye T; Liu X; Yang X; Zeng J; Yan L; Xing J; Xiao K; Ye Z; Xu H
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F137-F151. PubMed ID: 31091119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
